By understanding this change, we may be able to design pharmaceuticals or other forms of therapy that will assist individuals with this mutation in recovering from bacterial disease.

For the longest time, doctors suspected that the condition was caused by persistent, hidden bacterial infections and sometimes prescribed long-term or open-ended antibiotic therapy.

OBJECTIVE To analyze the epidemiology characteristic of bacterial infection after liver transplantation, and provide a basis to improve prophylaxis and empiric therapy.